3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
36
OTHER
33
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Esophageal Neoplasms
9
Stomach Neoplasms
7
Breast Neoplasms
7
Rectal Neoplasms
5
Brain Neoplasms
4
Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Radiation Injuries
2
Pain
2
Meningeal Carcinomatosis
2
Vomiting
1
Varicose Veins
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Thoracic Neoplasms
1
Solitary Pulmonary Nodule
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Skin Diseases
1
Sarcoidosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Non-Muscle Invasive Bladder Neoplasms
1
Neutropenia
1
Nasopharyngeal Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
UNKNOWN
×
Non-Muscle Invasive Bladder Neoplasms
×
Clear all
NCT03672240
2020-07-20
NMIBC
AsierisPharma
Phase 1/2
Completed
6 enrolled